Larvol Delta - Blue-Earth-Therapeutics-Announces-US-FDA-Clearance-for-Investigational-New-Drug-IND-Application-for-177LurhPSMA101-for-Treatment-of-Prostate-Cancer

177Lu-rhPSMA-10.1 - Bracco

https://www.businesswire.com/news/home/20220412005083/en/Blue-Earth-Therapeutics-Announces-U.S.-FDA-Clearance-for-Investigational-New-Drug-IND-Application-for-177Lu-rhPSMA-10.1-for-Treatment-of-Prostate-Cancer

Apr 12, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev